BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.70
-0.20 (-0.67%)
Aug 4, 2026, 12:57 PM CST
BioLASCO Taiwan Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 761 | 794 | 848 | 850 | 765 | 780 | |
Market Cap Growth | -12.65% | -6.34% | -0.30% | 11.22% | -1.97% | -13.74% |
Enterprise Value | 722 | 767 | 818 | 729 | 627 | 638 |
Last Close Price | 29.70 | 31.00 | 31.63 | 30.38 | 26.06 | 25.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.60 | 18.71 | 19.26 | 17.09 | 18.07 | 17.27 |
PS Ratio | 2.88 | 3.02 | 2.90 | 3.21 | 3.24 | 3.43 |
PB Ratio | 1.81 | 1.74 | 1.89 | 1.84 | 1.68 | 1.69 |
P/TBV Ratio | 1.81 | 1.74 | 1.89 | 1.85 | 1.68 | 1.69 |
P/FCF Ratio | 23.96 | 29.34 | 818.30 | 30.56 | 18.70 | 11.71 |
P/OCF Ratio | 14.00 | 16.30 | 14.91 | 28.86 | 17.11 | 11.01 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.74 | 2.92 | 2.80 | 2.75 | 2.66 | 2.80 |
EV/EBITDA Ratio | 11.43 | 12.87 | 12.69 | 12.36 | 11.01 | 10.27 |
EV/EBIT Ratio | 14.52 | 15.96 | 14.68 | 14.36 | 12.72 | 11.83 |
EV/FCF Ratio | 22.74 | 28.33 | 789.69 | 26.19 | 15.33 | 9.57 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.22 | 0.21 | 0.24 | 0.13 | 0.14 | 0.15 |
Debt / EBITDA Ratio | 1.43 | 1.57 | 1.60 | 0.95 | 1.11 | 1.08 |
Debt / FCF Ratio | 2.84 | 3.47 | 103.29 | 2.09 | 1.61 | 1.04 |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.12 | -0.31 | -0.35 | -0.38 |
Net Debt / EBITDA Ratio | -0.63 | -0.71 | -0.86 | -2.43 | -2.83 | -2.82 |
Net Debt / FCF Ratio | -1.22 | -1.57 | -53.58 | -5.15 | -3.94 | -2.63 |
Asset Turnover | 0.44 | 0.44 | 0.49 | 0.46 | 0.41 | 0.39 |
Inventory Turnover | 5.36 | 4.65 | 4.93 | 5.30 | 5.77 | 6.06 |
Quick Ratio | 1.94 | 3.23 | 3.04 | 4.18 | 4.58 | 5.48 |
Current Ratio | 2.33 | 3.93 | 3.66 | 4.83 | 5.09 | 5.93 |
Return on Equity (ROE) | 10.33% | 9.35% | 9.67% | 10.86% | 9.25% | 9.73% |
Return on Assets (ROA) | 5.20% | 4.98% | 5.88% | 5.55% | 5.38% | 5.79% |
Return on Invested Capital (ROIC) | 10.59% | 10.17% | 12.56% | 13.33% | 13.56% | 14.81% |
Return on Capital Employed (ROCE) | 9.90% | 8.90% | 10.20% | 9.90% | 9.60% | 10.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.70% | 5.34% | 5.19% | 5.85% | 5.53% | 5.79% |
FCF Yield | 4.17% | 3.41% | 0.12% | 3.27% | 5.35% | 8.54% |
Dividend Yield | 5.02% | - | 4.74% | 5.43% | 5.76% | 6.36% |
Payout Ratio | 88.54% | 90.55% | 95.98% | 77.23% | 96.85% | 113.45% |
Buyback Yield / Dilution | -0.28% | -0.24% | 0.02% | 0.00% | 0.02% | 0.03% |
Total Shareholder Return | 4.53% | -0.24% | 4.76% | 5.43% | 5.77% | 6.39% |